Pharma ETFs to Gain From Landmark UK-US Zero-Tariff Deal

Pharma ETFs like IHE are poised to surge as the UK-US zero-tariff deal raises UK drug prices and strengthens major U.S. players' outlook.

Zacks Investment Research • Dec 9, 2025

Britain will spend more on new medicines in exchange for avoiding tariffs on U.K. pharmaceutical exports to the U.S.

The move marks a victory for the Trump administration's campaign to get other countries to pay more for drugs.

WSJ • Dec 1, 2025

Should You Invest in the VanEck Pharmaceutical ETF (PPH)?

Looking for broad exposure to the Healthcare - Pharma segment of the equity market? You should consider the VanEck Pharmaceutical ETF (PPH), a passively managed exchange traded fund launched on December 20, 2011.

Zacks Investment Research • Nov 27, 2025

Ozempic—and 14 other popular prescription drugs—will cost less for Medicare after the U.S. government negotiated lower prices

The price cuts will save Medicare billions of dollars in prescription-drug spending.

WSJ • Nov 25, 2025

3 Best Healthcare Stocks: Quant Strong Buys From Goldman's 'Alpha' List

The healthcare sector's renewed momentum offers fertile ground for investors wanting to outperform by picking the best stocks from the broader indexes. Goldman Sachs identified 29 healthcare stocks in the Russell 1000 universe with positive recent consensus revisions to 2026 EPS estimates and that trade at attractive valuations. Goldman sees "more opportunity for alpha than beta" as wide return dispersion and increasing M&A activity in healthcare may favor selected winners.

Seeking Alpha • Nov 17, 2025

Investing In Health Stocks - How Policy Clarity Is Opening Doors

The healthcare sector has experienced one of its most significant de-ratings in 35 years, with valuations now at a 30% discount to the broader market. Healthcare trades at historical valuation discounts across multiple metrics.

Seeking Alpha • Nov 11, 2025

Top Pharmaceutical Companies Shaping the Future of Healthcare

Pharma's strong pipelines, reduced policy risks, and demand growth drive renewed investor interest. PPH offers targeted access to top innovators like Eli Lilly and Merck.

ETF Trends • Nov 1, 2025

Drug Stocks Just Had Their Best Week in 2 Decades. Should You Invest?

Pharmaceutical stocks are having a moment. The S&P 500 Pharmaceuticals Index recently rose 11% during five trading days, its best weekly gain since 2022.

The Motley Fool • Oct 13, 2025

Final Trade: JCI, PPH, TOL, IBM

The final trades of the day with the Fast Money traders.

CNBC Television • Oct 7, 2025

4 Reasons to Buy Pharma ETFs Now for a Healthy Portfolio

Pharma's Trump-Pfizer boost sparks momentum, making ETFs PPH, IHE, PJP & XPH attractive for defensive, undervalued growth plays.

Zacks Investment Research • Oct 6, 2025